KEWAUNEE SCIENTIFIC CP (KEQU) Fundamental Analysis & Valuation

NASDAQ:KEQU • US4928541048

Current stock price

36.86 USD
+0.16 (+0.44%)
Last:

This KEQU fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. KEQU Profitability Analysis

1.1 Basic Checks

  • In the past year KEQU was profitable.
  • In the past year KEQU had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: KEQU reported negative net income in multiple years.
  • In multiple years KEQU reported negative operating cash flow during the last 5 years.
KEQU Yearly Net Income VS EBIT VS OCF VS FCFKEQU Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M -5M 10M 15M

1.2 Ratios

  • With an excellent Return On Assets value of 6.30%, KEQU belongs to the best of the industry, outperforming 83.42% of the companies in the same industry.
  • The Return On Equity of KEQU (15.68%) is better than 89.84% of its industry peers.
  • With an excellent Return On Invested Capital value of 12.17%, KEQU belongs to the best of the industry, outperforming 93.05% of the companies in the same industry.
  • KEQU had an Average Return On Invested Capital over the past 3 years of 9.90%. This is in line with the industry average of 9.12%.
  • The 3 year average ROIC (9.90%) for KEQU is below the current ROIC(12.17%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 6.3%
ROE 15.68%
ROIC 12.17%
ROA(3y)6.79%
ROA(5y)2.22%
ROE(3y)17.94%
ROE(5y)5.55%
ROIC(3y)9.9%
ROIC(5y)N/A
KEQU Yearly ROA, ROE, ROICKEQU Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 30

1.3 Margins

  • The Profit Margin of KEQU (3.85%) is better than 75.40% of its industry peers.
  • KEQU has a better Operating Margin (6.95%) than 73.80% of its industry peers.
  • KEQU's Gross Margin of 28.93% is on the low side compared to the rest of the industry. KEQU is outperformed by 74.87% of its industry peers.
  • KEQU's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 6.95%
PM (TTM) 3.85%
GM 28.93%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y25.96%
GM growth 5Y12.54%
KEQU Yearly Profit, Operating, Gross MarginsKEQU Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. KEQU Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so KEQU is still creating some value.
  • The number of shares outstanding for KEQU remains at a similar level compared to 1 year ago.
  • Compared to 5 years ago, KEQU has more shares outstanding
  • Compared to 1 year ago, KEQU has a worse debt to assets ratio.
KEQU Yearly Shares OutstandingKEQU Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500K 1M 1.5M 2M 2.5M
KEQU Yearly Total Debt VS Total AssetsKEQU Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

2.2 Solvency

  • KEQU has an Altman-Z score of 3.50. This indicates that KEQU is financially healthy and has little risk of bankruptcy at the moment.
  • With a decent Altman-Z score value of 3.50, KEQU is doing good in the industry, outperforming 70.59% of the companies in the same industry.
  • The Debt to FCF ratio of KEQU is 2.61, which is a good value as it means it would take KEQU, 2.61 years of fcf income to pay off all of its debts.
  • With an excellent Debt to FCF ratio value of 2.61, KEQU belongs to the best of the industry, outperforming 82.89% of the companies in the same industry.
  • A Debt/Equity ratio of 0.62 indicates that KEQU is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.62, KEQU is doing worse than 65.78% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF 2.61
Altman-Z 3.5
ROIC/WACC1.56
WACC7.81%
KEQU Yearly LT Debt VS Equity VS FCFKEQU Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M 40M 60M

2.3 Liquidity

  • KEQU has a Current Ratio of 2.12. This indicates that KEQU is financially healthy and has no problem in meeting its short term obligations.
  • KEQU has a worse Current ratio (2.12) than 60.43% of its industry peers.
  • KEQU has a Quick Ratio of 1.45. This is a normal value and indicates that KEQU is financially healthy and should not expect problems in meeting its short term obligations.
  • KEQU has a Quick ratio of 1.45. This is in the lower half of the industry: KEQU underperforms 64.17% of its industry peers.
Industry RankSector Rank
Current Ratio 2.12
Quick Ratio 1.45
KEQU Yearly Current Assets VS Current LiabilitesKEQU Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. KEQU Growth Analysis

3.1 Past

  • KEQU shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -37.07%.
  • KEQU shows a strong growth in Revenue. In the last year, the Revenue has grown by 30.78%.
  • Measured over the past years, KEQU shows a quite strong growth in Revenue. The Revenue has been growing by 10.27% on average per year.
EPS 1Y (TTM)-37.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-74.31%
Revenue 1Y (TTM)30.78%
Revenue growth 3Y12.5%
Revenue growth 5Y10.27%
Sales Q2Q%3.32%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
KEQU Yearly Revenue VS EstimatesKEQU Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
KEQU Yearly EPS VS EstimatesKEQU Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 0.5 1 1.5

More info and screens

Find the best growth stocksShow best growing peers

5

4. KEQU Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 8.69, which indicates a very decent valuation of KEQU.
  • 94.12% of the companies in the same industry are more expensive than KEQU, based on the Price/Earnings ratio.
  • When comparing the Price/Earnings ratio of KEQU to the average of the S&P500 Index (27.95), we can say KEQU is valued rather cheaply.
Industry RankSector Rank
PE 8.69
Fwd PE N/A
KEQU Price Earnings VS Forward Price EarningsKEQU Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of KEQU indicates a rather cheap valuation: KEQU is cheaper than 97.33% of the companies listed in the same industry.
  • Based on the Price/Free Cash Flow ratio, KEQU is valued cheaper than 98.93% of the companies in the same industry.
Industry RankSector Rank
P/FCF 5.55
EV/EBITDA 5.52
KEQU Per share dataKEQU EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

  • KEQU has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. KEQU Dividend Analysis

5.1 Amount

  • No dividends for KEQU!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

KEQU Fundamentals: All Metrics, Ratios and Statistics

KEWAUNEE SCIENTIFIC CP

NASDAQ:KEQU (4/20/2026, 8:12:33 PM)

36.86

+0.16 (+0.44%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-11
Earnings (Next)06-23
Inst Owners42.06%
Inst Owner Change1.92%
Ins Owners15.69%
Ins Owner Change-1.37%
Market Cap105.79M
Revenue(TTM)287.75M
Net Income(TTM)11.08M
Analysts82.86
Price TargetN/A
Short Float %1.84%
Short Ratio7.32
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 8.69
Fwd PE N/A
P/S 0.37
P/FCF 5.55
P/OCF 4.69
P/B 1.5
P/tB 2.55
EV/EBITDA 5.52
EPS(TTM)4.24
EY11.5%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)6.64
FCFY18.01%
OCF(TTM)7.87
OCFY21.34%
SpS100.26
BVpS24.63
TBVpS14.46
PEG (NY)N/A
PEG (5Y)N/A
Graham Number48.4692 (31.5%)
Profitability
Industry RankSector Rank
ROA 6.3%
ROE 15.68%
ROCE 15.73%
ROIC 12.17%
ROICexc 13%
ROICexgc 17.14%
OM 6.95%
PM (TTM) 3.85%
GM 28.93%
FCFM 6.62%
ROA(3y)6.79%
ROA(5y)2.22%
ROE(3y)17.94%
ROE(5y)5.55%
ROIC(3y)9.9%
ROIC(5y)N/A
ROICexc(3y)12.02%
ROICexc(5y)N/A
ROICexgc(3y)13.16%
ROICexgc(5y)N/A
ROCE(3y)12.97%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y25.96%
GM growth 5Y12.54%
F-Score6
Asset Turnover1.64
Health
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF 2.61
Debt/EBITDA 1.67
Cap/Depr 55.94%
Cap/Sales 1.23%
Interest Coverage 4.36
Cash Conversion 85.86%
Profit Quality 171.98%
Current Ratio 2.12
Quick Ratio 1.45
Altman-Z 3.5
F-Score6
WACC7.81%
ROIC/WACC1.56
Cap/Depr(3y)110.02%
Cap/Depr(5y)97.64%
Cap/Sales(3y)1.65%
Cap/Sales(5y)1.54%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-37.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-74.31%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)30.78%
Revenue growth 3Y12.5%
Revenue growth 5Y10.27%
Sales Q2Q%3.32%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y34.97%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y56.25%
FCF growth 3YN/A
FCF growth 5Y49.49%
OCF growth 1Y24.21%
OCF growth 3YN/A
OCF growth 5Y28.86%

KEWAUNEE SCIENTIFIC CP / KEQU Fundamental Analysis FAQ

What is the ChartMill fundamental rating of KEWAUNEE SCIENTIFIC CP (KEQU) stock?

ChartMill assigns a fundamental rating of 5 / 10 to KEQU.


What is the valuation status of KEWAUNEE SCIENTIFIC CP (KEQU) stock?

ChartMill assigns a valuation rating of 5 / 10 to KEWAUNEE SCIENTIFIC CP (KEQU). This can be considered as Fairly Valued.


Can you provide the profitability details for KEWAUNEE SCIENTIFIC CP?

KEWAUNEE SCIENTIFIC CP (KEQU) has a profitability rating of 6 / 10.


What is the valuation of KEWAUNEE SCIENTIFIC CP based on its PE and PB ratios?

The Price/Earnings (PE) ratio for KEWAUNEE SCIENTIFIC CP (KEQU) is 8.69 and the Price/Book (PB) ratio is 1.5.